The oxygen dissociation curve of blood in COVID-19
- PMID: 33978488
- PMCID: PMC8384474
- DOI: 10.1152/ajplung.00079.2021
The oxygen dissociation curve of blood in COVID-19
Abstract
COVID-19 hinders oxygen transport to the consuming tissues by at least two mechanisms: In the injured lung, saturation of hemoglobin is compromised, and in the tissues, an associated anemia reduces the volume of delivered oxygen. For the first problem, increased hemoglobin oxygen affinity [left shift of the oxygen dissociation curve (ODC)] is of advantage, for the second, however, the contrary is the case. Indeed a right shift of the ODC has been found in former studies for anemia caused by reduced cell production or hemolysis. This resulted from increased 2,3-bisphosphoglycerate (2,3-BPG) concentration. In three investigations in COVID-19, however, no change of hemoglobin affinity was detected in spite of probably high [2,3-BPG]. The most plausible cause for this finding is formation of methemoglobin (MetHb), which increases the oxygen affinity and thus apparently compensates for the 2,3-BPG effect. However, this "useful effect" is cancelled by the concomitant reduction of functional hemoglobin. In the largest study on COVID-19, even a clear left shift of the ODC was detected when calculated from measurements in fresh blood rather than after equilibration with gases outside the body. This additional "in vivo" left shift possibly results from various factors, e.g., concentration changes of Cl-, 2,3-BPG, ATP, lactate, nitrocompounds, glutathione, glutamate, because of time delay between blood sampling and end of equilibration, or enlarged distribution space including interstitial fluid and is useful for O2 uptake in the lungs. Under discussion for therapy are the affinity-increasing 5-hydroxymethyl-2-furfural (5-HMF), erythropoiesis-stimulating substances like erythropoietin, and methylene blue against MetHb formation.
Keywords: anemia; half-saturation pressure; hemoglobin oxygen affinity; in vivo oxygen dissociation curve; methemoglobin.
Conflict of interest statement
No conflicts of interest, financial or otherwise, are declared by the authors.
Figures
Comment in
-
How to increase cellular oxygen availability in COVID-19?Acta Physiol (Oxf). 2021 Oct;233(2):e13724. doi: 10.1111/apha.13724. Epub 2021 Aug 11. Acta Physiol (Oxf). 2021. PMID: 34351690 Free PMC article. No abstract available.
-
The increased hemoglobin oxygen affinity in COVID-19.Am J Physiol Lung Cell Mol Physiol. 2021 Sep 1;321(3):L637. doi: 10.1152/ajplung.00280.2021. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 34491859 Free PMC article. No abstract available.
-
Reply to Vogel et al.Am J Physiol Lung Cell Mol Physiol. 2021 Sep 1;321(3):L638-L639. doi: 10.1152/ajplung.00327.2021. Am J Physiol Lung Cell Mol Physiol. 2021. PMID: 34491860 Free PMC article. No abstract available.
-
Reply to Gille et al.Am J Physiol Lung Cell Mol Physiol. 2022 Jan 1;322(1):L176-L177. doi: 10.1152/ajplung.00461.2021. Am J Physiol Lung Cell Mol Physiol. 2022. PMID: 35015567 Free PMC article. No abstract available.
-
Is there a shift of the oxygen-hemoglobin dissociation curve in COVID-19?Am J Physiol Lung Cell Mol Physiol. 2022 Jan 1;322(1):L174-L175. doi: 10.1152/ajplung.00390.2021. Am J Physiol Lung Cell Mol Physiol. 2022. PMID: 35015569 Free PMC article. No abstract available.
References
-
- Gagiannis D, Steinestel J, Hackenbroch C, Schreiner B, Hannemann M, Bloch W, Umathum VG, Gebauer N, Rother C, Stahl M, Witte HM, Steinestel K. Clinical, serological, and histopathological similarities between severe COVID-19 and acute exacerbation of connective tissue disease-associated interstitial lung disease (CTD-ILD). Front Immunol 11: 587517, 2020. doi: 10.3389/fimmu.2020.587517. - DOI - PMC - PubMed
-
- Piiper J. Pulmonary gas exchange. In: Comprehensive Human Physiology, edited by Greger R, Windhorst U.. Berlin-Heidelberg-New York: Springer, 1996, p. 2037–2049.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
